Lixte Biotechnology has been granted a patent for a method involving the in vivo delivery of endothall to cancer cells in cancer patients. The method includes administering a specific compound with a defined structure. GlobalData’s report on Lixte Biotechnology gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Lixte Biotechnology, Cancer treatment biomarkers was a key innovation area identified from patents. Lixte Biotechnology's grant share as of February 2024 was 36%. Grant share is based on the ratio of number of grants to total number of patents.
In vivo delivery of endothall to cancer cells
A recently granted patent (Publication Number: US11866444B2) discloses a method for delivering endothall to cancer cells in vivo in patients with cancer. The method involves administering a compound with a specific structure to the patient. The patent claims cover the delivery of endothall specifically to brain cancer cells, including various types such as glioma, pilocytic astrocytoma, and glioblastoma multiforme, among others.
Furthermore, the method outlined in the patent also includes the administration of an anti-cancer agent along with the compound to enhance the treatment efficacy. The specific structures of the compound mentioned in the claims indicate the precise chemical composition required for effective delivery of endothall to the cancer cells. This patent represents a significant development in the field of cancer treatment, particularly for brain cancer, by providing a targeted approach for delivering therapeutic agents to the affected cells.
To know more about GlobalData’s detailed insights on Lixte Biotechnology, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
